Edmond de Rothschild (Suisse)’s Teva Pharmaceuticals TEVA Stock Holding History

Edmond de Rothschild (Suisse)’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$169K	Buy	3,680 +1,000	+37%	+$52.2K	0.05%	218
2016 Q2	$135K	Buy	2,680 +400	+18%	+$21.3K	0.04%	210
2016 Q1	$122K	Hold	2,280	–	–	0.05%	184
2015 Q4	$150K	Sell	2,280 -540	-19%	-$33.4K	0.06%	163
2015 Q3	$159K	Hold	2,820	–	–	0.05%	169
2015 Q2	$167K	Buy	+2,820	New	+$174K	0.05%	172

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Edmond de Rothschild (Suisse)'s TEVA Position: Q3 2016 in Review

Edmond de Rothschild (Suisse) increased its Teva Pharmaceuticals (TEVA) stake by 37% in Q3 2016, buying an estimated $52.2K and bringing the position to 3,680 shares worth $169K. The position accounts for 0.05% of the portfolio, ranked #218.

Edmond de Rothschild (Suisse) first reported a position in TEVA in Q2 2015 and has held it in 6 quarters since. 797 funds tracked by Wall St. Rank hold TEVA as of Q3 2016.

Edmond de Rothschild (Suisse) held 3,680 shares of Teva Pharmaceuticals worth $169K as of Q3 2016.
Edmond de Rothschild (Suisse) bought 1,000 Teva Pharmaceuticals shares in Q3 2016, an estimated $52.2K.
Teva Pharmaceuticals made up 0.05% of Edmond de Rothschild (Suisse)'s portfolio in Q3 2016, its #218 holding.
Edmond de Rothschild (Suisse) first reported a position in Teva Pharmaceuticals in Q2 2015 and has held it in 6 quarters since.
797 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2016.

Based on Edmond de Rothschild (Suisse)'s 13F filing for Q3 2016, filed 14 Nov 2016.